Last $1.45 USD
Change Today +0.05 / 3.57%
Volume 817.8K
PPHM On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Stephen M. Smith M.D.

Former Member of the Medical Advisory Board, Peregrine Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 23 board members in 2 different organizations across 3 different industries.

See Board Relationships
----

Background*

Stephen M. Smith, M.D., serves as Chief of Infectious Diseases at St. Michael’s Medical Center in New Jersey. Dr. Smith serves as Medical Director of the Peter Ho Memorial Clinic at Saint Michael’s, the largest HIV clinic in New Jersey. He also serves as Program Director of the Infectious Diseases Fellowship Program at Seton Hall School of Graduate Medical Education. Dr. Smith is a board-certified infectious diseases specialist with extensive training and experience ...

Read Full Background

Corporate Headquarters*

14282 Franklin Avenue
Tustin, California 92780

United States

Phone: 714-508-6000
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Unknown/Other Education
University of Virginia
Unknown/Other Education
Yale University School Of Medicine
Doctorate
Yale University School Of Medicine
BA 1985
Duke University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PPHM:US $1.45 USD +0.05

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
J. Joseph Kim Ph.D.Chief Executive Officer, President, Director and Member of Finance Committee
Inovio Pharmaceuticals, Inc.
$852.8K
Vijay B. Samant Chief Executive Officer, President, Acting Chief Financial Officer and Director
Vical Incorporated
$557.0K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$533.3K
Daniel J. O’Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
$312.5K
William D. Clark Chief Executive Officer, President and Director
Genocea Biosciences, Inc.
$334.3K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PEREGRINE PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.